RE
ORTX

RBC Europe’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

RBC Europe’s Portfolio ORTX Stock Details ORTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,950
Closed -$14K – 666
2022
Q1 		$14K Buy
1,950
+1,850
+1,850% +$18.1K ﹤0.01% 498
2021
Q4 		$1K Buy
+100
New +$1.65K ﹤0.01% 623

Other funds holding ORTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

RBC Europe's ORTX Position: Q2 2022 in Review

RBC Europe sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q2 2022, closing a stake of 1,950 shares — an estimated $14K sold.

RBC Europe first reported a position in ORTX in Q4 2021 and held it in 2 quarters. The position peaked at $14K in Q1 2022. 50 funds tracked by Wall St. Rank hold ORTX as of Q2 2022.

  • RBC Europe reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q2 2022 after selling out during the quarter.
  • RBC Europe sold 1,950 Orchard Therapeutics plc American Depositary Shares shares in Q2 2022, an estimated $14K.
  • RBC Europe first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and held it in 2 quarters.
  • RBC Europe's Orchard Therapeutics plc American Depositary Shares position peaked at $14K in Q1 2022.
  • 50 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.